Authorization of Notes Clause Samples

Authorization of Notes. The Company will authorize the issue and sale of $250,000,000 aggregate principal amount of its 4.29% Senior Guaranteed Notes, Series D, due March 1, 2027, (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule A. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of €125,000,000 aggregate principal amount of its 1.47% Senior Notes due June 17, 2030 (the “Notes,” such term to include any notes issued in substitution therefor pursuant to Section 13). The Notes shall be substantially in the form set out in Exhibit 1, with such changes therefrom, if any, as may be approved by the Purchasers and the Company. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company will authorize the issue and sale of $84,500,000 aggregate principal amount of its 3.26% Senior Secured Notes due December 31, 2024 (as amended, restated or otherwise modified from time to time pursuant to Article 17 and including any such notes issued in substitution therefor pursuant to Article 13, and together with the Parent Guarantees to be endorsed thereon, the “Notes”). The Notes shall be substantially in the form set out in Schedule 1. Certain capitalized and other terms used in this Agreement are defined in Schedule A; and references to a “Schedule” or an “Exhibit” are to a Schedule or an Exhibit attached to this Agreement unless otherwise specified. References to an “Article” or a “Section” are references to an Article or Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of $100,000,000 aggregate principal amount of its 3.95% Senior Notes due July 10, 2027 (as amended, restated or otherwise modified from time to time pursuant to Section 17 and including any such notes issued in substitution therefor pursuant to Section 13, the “Notes”). The Notes shall be substantially in the form set out in Exhibit 1. Certain capitalized and other terms used in this Agreement are defined in Schedule B. References to a “Schedule” are references to a Schedule attached to this Agreement unless otherwise specified. References to a “Section” are references to a Section of this Agreement unless otherwise specified.

Authorization of Notes. The Company will authorize the issue and sale of (a) $205,000,000 aggregate principal amount of its 6.28% Senior Notes, Series A, due June 26, 2015 (the “Series A Notes”) and (b) $145,000,000 aggregate principal amount of its 6.72% Senior Notes, Series B, due June 26, 2018 (the “Series B Notes”; the Series A Notes and the Series B Notes being hereinafter collectively referred to as the “Notes”, such term to include any such notes issued in substitution therefor pursuant to Section 13). The Notes shall be substantially in the form set out in Exhibit 1 or Exhibit 2, as the case may be. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Company has authorized the issue and sale of $56,000,000 aggregate principal amount of its Senior Notes consisting of (a) $14,000,000 aggregate principal amount of its 3.83% Senior Notes, Series 2013A, due July 1, 2020, (the “Series A Notes”), (b) $12,000,000 aggregate principal amount of its 4.45% Senior Notes, Series 2013B, due December 1, 2022 (the “Series B Notes”) and (c) $30,000,000 aggregate principal amount of its 4.84% Senior Notes, Series 2013C, due October 1, 2027 (the “Series C Notes”). The Series A Notes, the Series B Notes and the Series C Notes are herein collectively referred to as the “Notes.” As used herein, the term “Notes” shall mean all notes (irrespective of series unless otherwise specified) originally delivered pursuant to this Agreement and any such notes issued in substitution therefor pursuant to Section 14. The Series A Notes, the Series B Notes and the Series C Notes shall be substantially in the forms set out in Exhibit 1(a), Exhibit 1(b) and Exhibit 1(c), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule B; and references to a “Schedule” or an “Exhibit” are, unless otherwise specified, to a Schedule or an Exhibit attached to this Agreement.

Authorization of Notes. The Issuer will authorize the issue and sale of $240,000,000 aggregate principal of its Guaranteed Senior Notes, of which $120,000,000 aggregate principal amount shall be its 4.69% Series A Guaranteed Senior Notes due January 10, 2026 (the “Series A Notes”) and $120,000,000 aggregate principal amount shall be its 4.79% Series B Guaranteed Senior Notes due January 10, 2028 (the “Series B Notes”; the Series A Notes and the Series B Notes are hereinafter referred to collectively as the “Notes”). The Series A Notes and the Series B Notes shall be substantially in the forms set out in Schedule 1(a) and Schedule 1(b), respectively. Certain capitalized and other terms used in this Agreement are defined in Schedule A and, for purposes of this Agreement, the rules of construction set forth in Section 23.4 shall govern.

Authorization of Notes. This Note Purchase Agreement (the "Agreement") is entered into between G▇▇▇▇ Capital BDC CLO 4 LLC, a Delaware limited liability company (the "Issuer") and W▇▇▇▇ Fargo Securities, LLC, as the initial purchaser (in such capacity, the "Initial Purchaser"). Subject to the terms and conditions stated in this Agreement, the Issuer propose to issue and sell to the Initial Purchaser (i) U.S.$137,500,000 Class A-1 Senior Secured Floating Rate Notes due 2032 (the "Class A-1 Notes"), (ii) U.S.$10,500,000 Class A-2 Senior Secured Floating Rate Notes due 2032 (the "Class A-2 Notes") and (iii) U.S.$21,000,000 Class B Senior Secured Floating Rate Notes due 2032 (the "Class B Notes"). Subject to the terms and conditions stated in this Agreement, the Issuer also proposes to issue (i) up to U.S.$33,000,000 of the Class C Secured Deferrable Floating Rate Notes due 2032 (the "Class C Notes" and, together with the Class A-1 Notes, the Class A-2 Notes and the Class B Notes, the "Secured Notes"), the principal amount of which will be zero on the Closing Date and (ii) U.S.$108,355,000 principal amount of Subordinated Notes due 2120 (the "Subordinated Notes" and, together with the Secured Notes, the "Notes"). The Class A-1 Notes, the Class A-2 Notes and the Class B Notes to be issued and sold to the Initial Purchaser are referred to herein as the "Purchased Notes" and are set forth on Schedule I hereto. The Secured Notes being offered by the Initial Purchaser are referred to herein as the "Offered Notes". Any Subordinated Notes which the Issuer intends to sell directly to G▇▇▇▇ Capital BDC CLO 4 Depositor LLC (the "Purchaser") or any Related Entity are referred to herein as the "Direct Placement Notes" (provided that the Initial Purchaser may facilitate the settlement of the Direct Placement Notes solely as an accommodation to the Issuer and the initial purchasers of the Direct Placement Notes). Any reference herein to the sale of the Notes to or by the Initial Purchaser shall include the distribution to, and sale by, the Initial Purchaser to the extent reflected as such on Schedule I hereto. On the Closing Date, the Issuer will also enter into the Class A-1-L Credit Agreement (the "Credit Agreement") between the Issuer, Deutsche Bank Trust Company Americas, as the collateral agent and the loan agent and the lenders party thereto from time to time, pursuant to which the Issuer will incur U.S.$20,000,000 Class A-1-L Senior Secured Floating Rate Loans maturing 2032 (the "Class A-1-...

Authorization of Notes. The Company will authorize the issue and sale of (a) $80,000,000 aggregate principal amount of its 6.71% Series A Senior Notes due February 27, 2008 (the "Series A Notes") and (b) $20,000,000 aggregate principal amount of its 6.60% Series B Senior Notes due February 27, 2005 (the "Series B Notes").